July 8, 2020
Section 301 Tariff Update
Over the past few months, there have been a number of new developments regarding the Section 301 Tariffs which impact a number of healthcare supplies. The newest Policy Insights document from HIDA Government Affairs provides brief summaries of:
- Actions taken by the Trump Administration around Section 301 Tariffs
- Actions taken by various trade groups around Section 301 Tariffs
- The recently released US International Trade Commission Report on the impact of tariffs on COVID-19 related goods
Access the Policy Insights document►
Additionally, HIDA recently submitted comments to the United States Trade Representative (USTR) about the impact of tariffs on the response to COVID-19.
Read HIDA comments to USTR►
If you have any questions, please reach out to HIDA Government Affairs at HIDAGovAffairs@HIDA.org.